Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2007 3
2008 4
2009 3
2010 1
2011 2
2012 1
2013 3
2014 12
2015 15
2016 10
2017 6
2018 5
2019 1
2020 6
2021 8
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.
Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators. Williams TA, et al. Among authors: rottenkolber m. Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30. Lancet Diabetes Endocrinol. 2017. PMID: 28576687 Free PMC article.
Adjustment for continuous confounders: an example of how to prevent residual confounding.
Groenwold RH, Klungel OH, Altman DG, van der Graaf Y, Hoes AW, Moons KG; PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]). Groenwold RH, et al. CMAJ. 2013 Mar 19;185(5):401-6. doi: 10.1503/cmaj.120592. Epub 2013 Feb 11. CMAJ. 2013. PMID: 23401401 Free PMC article. Review. No abstract available.
Antiepileptic drugs and suicide: a systematic review of adverse effects.
Ferrer P, Ballarín E, Sabaté M, Vidal X, Rottenkolber M, Amelio J, Hasford J, Schmiedl S, Ibáñez L. Ferrer P, et al. Among authors: rottenkolber m. Neuroepidemiology. 2014;42(2):107-20. doi: 10.1159/000356807. Epub 2014 Jan 3. Neuroepidemiology. 2014. PMID: 24401764 Free article. Review.
A Pathophysiology of Type 2 Diabetes Unrelated to Metabolic Syndrome.
Rottenkolber M, Gar C, Then C, Wanger L, Sacco V, Banning F, Potzel AL, Kern-Matschilles S, Nevinny-Stickel-Hinzpeter C, Grallert H, Hesse N, Seissler J, Lechner A. Rottenkolber M, et al. J Clin Endocrinol Metab. 2021 Apr 23;106(5):1460-1471. doi: 10.1210/clinem/dgab057. J Clin Endocrinol Metab. 2021. PMID: 33515032 Free PMC article.
Association between bisphosphonate use and COVID-19 related outcomes.
Thompson J, Wang Y, Dreischulte T, Barreiro O, Gonzalez RJ, Hanč P, Matysiak C, Neely HR, Rottenkolber M, Haskell T, Endres S, von Andrian UH. Thompson J, et al. Among authors: rottenkolber m. Elife. 2023 Aug 3;12:e79548. doi: 10.7554/eLife.79548. Elife. 2023. PMID: 37534876 Free PMC article.
Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).
Sabaté M, Ferrer P, Ballarín E, Rottenkolber M, Amelio J, Schmiedl S, Reynolds R, Klungel O, Ibáñez L; PROTECT Work Package 2. Sabaté M, et al. Among authors: rottenkolber m. Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):201-11. doi: 10.1111/bcpt.12358. Epub 2014 Dec 29. Basic Clin Pharmacol Toxicol. 2015. PMID: 25420967 Free article. Review.
74 results